EC Number   |
Inhibitors |
Structure |
|---|
    2.6.1.83 | (2-[(E)-[1-(4-chlorophenyl)-2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene]methyl]-1H-indol-1-yl)acetic acid |
14% inhibition at 0.01 mM |
   |
| 2.6.1.83 | (2-[(E)-[1-(4-methylphenyl)-2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene]methyl]-1H-indol-1-yl)acetic acid |
- |
|
| 2.6.1.83 | (2-[(E)-[1-methyl-3-(4-methylphenyl)-2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene]methyl]-1H-indol-1-yl)acetic acid |
17% inhibition at 0.01 mM |
|
| 2.6.1.83 | (2E)-2-cyano-3-[5-(dimethylamino)furan-2-yl]-N-(3,4-dimethylphenyl)prop-2-enamide |
14% inhibition at 0.01 mM |
|
| 2.6.1.83 | (2Z)-N'-nitro-2-[[5-(3-nitrophenyl)furan-2-yl]methylidene]hydrazinecarboximidamide |
13% inhibition at 0.01 mM |
|
| 2.6.1.83 | (3E)-1-[(4-methoxyphenyl)sulfonyl]-3-[4-oxo-3-(prop-2-en-1-yl)-2-thioxo-1,3-thiazolidin-5-ylidene]-1,3-dihydro-2H-indol-2-one |
18% inhibition at 0.01 mM |
|
| 2.6.1.83 | (3E)-1-[(4-methylphenyl)sulfonyl]-3-(4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)-1,3-dihydro-2H-indol-2-one |
25% inhibition at 0.01 mM |
|
| 2.6.1.83 | (3E)-3-[2-(2,4-dimethyl-1,3-thiazol-5-yl)-2-oxoethylidene]-3,4-dihydroquinoxalin-2(1H)-one |
18% inhibition at 0.01 mM |
|
| 2.6.1.83 | (3E)-3-[2-oxo-2-(thiophen-2-yl)ethylidene]-3,4-dihydroquinoxalin-2(1H)-one |
15% inhibition at 0.01 mM |
|
| 2.6.1.83 | (3Z)-3-(2,4-dimethoxybenzylidene)-5-phenylfuran-2(3H)-one |
14% inhibition at 0.01 mM |
|
